Churg-Strauss Syndrome or Eosinophilic Granulomatosis with Polyangiitis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-12-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/SINUSITIS1010024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Revised International Chapel Hill Consensus Conference nomenclature of vasculitides

  2016cited by this paper
• Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.

  2015cited by this paper
• Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

  2015cited by this paper
• Omalizumab treatment in patient with severe asthma and Eosinophilic Granulomatosis with Polyangiitis . A case report.

  2014cited by this paper
• Successful management of Churg–Strauss syndrome using omalizumab as adjuvant immunomodulatory therapy: First documented pediatric case

  2014cited by this paper
• Familial eosinophilic granulomatosis with polyangiitis in a mother and daughter

  2014cited by this paper
• 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

  2013cited by this paper
• Severe adult-onset asthma: A distinct phenotype.

  2013cited by this paper
• Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome.

  2013cited by this paper
• Cutting Edge Issues in the Churg–Strauss Syndrome

  2013cited by this paper
• EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

  2013cited by this paper
• Childhood-onset Eosinophilic Granulomatosis with Polyangiitis (formerly Churg-Strauss Syndrome): A Contemporary Single-center Cohort

  2013cited by this paper
• IgG4-related disease of the head and neck: CT and MR imaging manifestations.

  2012cited by this paper
• Effect of race/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitides

  2012cited by this paper
• PTPN22 R620W polymorphism in the ANCA-associated vasculitides.

  2012cited by this paper
• Serum biomarkers are similar in Churg–Strauss syndrome and hypereosinophilic syndrome

  2012cited by this paper
• IgG4-related disease.

  2012cited by this paper
• Role of Medical Therapy in the Management of Nasal Polyps

  2012cited by this paper
• Extended follow-up after stopping mepolizumab in relapsing/refractory Churg-Strauss syndrome.

  2012cited by this paper
• EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

  2012influential reference
• World Health Organization‐defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management

  2012influential reference
• A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients

  2012influential reference
• Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome.

  2011cited by this paper
• Anti-interleukin-5 antibody therapy in asthma and allerges

  2011influential reference
• The Five-Factor Score Revisited: Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort

  2011cited by this paper
• Diagnosis of Churg-Strauss syndrome: eotaxin-3 makes it easier.

  2011cited by this paper
• IgG4 immune response in Churg–Strauss syndrome

  2011influential reference
• Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.

  2011cited by this paper
• Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome.

  2011cited by this paper
• Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study.

  2011cited by this paper
• The Course of Asthma in Churg–Strauss Syndrome

  2011cited by this paper
• Sustained response to mepolizumab in refractory Churg-Strauss syndrome.

  2010cited by this paper
• CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome.

  2010cited by this paper
• Churg–Strauss syndrome manifested by appendicitis, cholecystitis and superficial micronodular liver lesions—an unusual clinicopathological presentation

  2010cited by this paper
• Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome.

  2010cited by this paper
• Lung involvement in Churg–Strauss syndrome as related to the activity of the disease

  2010cited by this paper
• Imaging appearance of granulomatous lesions of head and neck.

  2010cited by this paper
• Refining the definition of hypereosinophilic syndrome.

  2010influential reference
• Interferon-alpha for maintenance of remission in Churg-Strauss syndrome: a long-term observational study.

  2010cited by this paper
• Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener's granulomatosis and Churg-Strauss syndrome.

  2010cited by this paper
• Churg-Strauss Syndrome Versus Chronic Eosinophilic Pneumonia on High-Resolution Computed Tomographic Findings

  2010cited by this paper
• Pulmonary findings in Churg–Strauss syndrome in chest X-rays and high resolution computed tomography at the time of initial diagnosis

  2010cited by this paper
• The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

  2010cited by this paper
• Cardiac involvement in Churg-Strauss syndrome.

  2010cited by this paper
• Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.

  2010cited by this paper
• Cardiac Involvement in Churg-Strauss Syndrome: Impact of Endomyocarditis

  2009cited by this paper
• A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

  2009cited by this paper
• Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients.

  2009cited by this paper
• Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients

  2009cited by this paper
• Churg-strauss syndrome in patients treated with omalizumab.

  2009cited by this paper
• Churg-Strauss angiitis.

  2009cited by this paper
• The emergence of antineutrophil cytoplasmic antibodies may precede the clinical onset of Churg-Strauss syndrome.

  2009cited by this paper
• Churg-Strauss syndrome.

  2009influential reference
• Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.

  2008cited by this paper
• Stable incidence of systemic vasculitides in schleswig-holstein, Germany.

  2008cited by this paper
• Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.

  2008cited by this paper
• Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al.

  2008cited by this paper
• Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.

  2008cited by this paper
• High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients

  2008cited by this paper
• Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production.

  2008cited by this paper
• The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case–crossover study

  2008cited by this paper
• A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome.

  2008cited by this paper
• Nasal Polyposis in Churg‐Strauss Syndrome

  2008cited by this paper
• Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients.

  2007cited by this paper
• Peripheral neuropathy in Wegener’s granulomatosis, Churg–Strauss syndrome and microscopic polyangiitis

  2007cited by this paper
• Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview.

  2007cited by this paper
• The common allergens in the Churg–Strauss syndrome

  2007cited by this paper
• Rhinitis of granulomatous and vasculitic diseases.

  2007cited by this paper
• Pulmonary eosinophilic syndromes.

  2007cited by this paper
• Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.

  2007cited by this paper
• Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings

  2007cited by this paper
• HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome.

  2007cited by this paper
• Ear, nose and throat manifestations of Churg-Strauss syndrome

  2006cited by this paper
• Churg-Strauss Syndrome

  2006cited by this paper
• Rituximab in Churg-Strauss syndrome

  2006cited by this paper
• Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.

  2005influential reference
• Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome.

  2005influential reference
• What is known about the epidemiology of the vasculitides?

  2005cited by this paper
• Nasal manifestations of systemic illnesses

  2004cited by this paper
• Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate.

  2004cited by this paper
• Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death.

  2004cited by this paper
• Churg Strauss syndrome--successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment.

  2004cited by this paper
• Large Bowel Obstruction Heralding Churg-Strauss Syndrome

  2004cited by this paper
• Churg-Strauss Syndrome

  2004cited by this paper
• Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome

  2004cited by this paper
• Are environmental factors important in primary systemic vasculitis? A case-control study.

  2003cited by this paper
• Churg-Strauss syndrome.

  2003cited by this paper
• Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists.

  2003cited by this paper
• Asthma therapies and Churg-Strauss syndrome.

  2002cited by this paper
• Leukotriene antagonists and Churg-Strauss syndrome: the smoking gun.

  1999cited by this paper
• Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.

  1999cited by this paper
• Interferon- Treatment of Four Patients with the Churg-Strauss Syndrome

  1998cited by this paper
• Asthma drug linked with Churg-Strauss syndrome

  1997cited by this paper
• Macrolide-induced Churg-Strauss syndrome in patient with atopy.

  1997cited by this paper
• Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.

  1996cited by this paper
• Comparison of Sinus Computed Tomography Staging Systems

  1995cited by this paper
• Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

  1994influential reference
• Limited forms of Churg-Strauss syndrome.

  1993cited by this paper
• Staging in rhinosinusitus.

  1993cited by this paper
• Limited forms of Churg-Strauss syndrome.

  1993cited by this paper

• Diagnostic Salivary Gland Biopsy in Pediatric Eosinophilic Granuolmatosis with Polyangiitis

  2025cites this paper
• Chronic rhinosinusitis with nasal polyps as the first stage in the development of eosinophilic granulomatosis with polyangiitis

  2024cites this paper
• Churg-Strauss Syndrome

  2021cites this paper
• Handbook of Renal Biopsy Pathology

  2020cites this paper
• Eosinophilic Vasculitis

  2020cites this paper
• Eosinophilic Granulomatosis with Polyangiitis in a 4-Year-Old Child: Is Montelukast and/or Clarithromycin a Trigger?

  2019cites this paper
• International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

  2018cites this paper
• AZ EOZINOFIL GRANULOMATOSIS POLYANGIITISSEL (EGPA)

  year unknowncites this paper